These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10333385)

  • 21. Role of 21-deoxyaldosterone in human hypertension.
    Abdelhamid S; Lewicka S; Bige K; Haack D; Lorenz H; Nensel U; Röckel A; Fiegel P; Walb D; Vecsei P
    J Steroid Biochem Mol Biol; 1994 Sep; 50(5-6):319-27. PubMed ID: 7918119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renin-angiotensin-aldosterone system in blood pressure regulation disorders].
    Kaufmann W
    Verh Dtsch Ges Inn Med; 1968; 74():56-79. PubMed ID: 4306317
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition by heparinoid of aldosterone biosynthesis in man.
    Conn JW; Rovner DR; Cohen EL; Anderson JE
    J Clin Endocrinol Metab; 1966 May; 26(5):527-32. PubMed ID: 4160937
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of the renin-angiotensin system in the adaptation of aldosterone biosynthesis to sodium restriction in the rat.
    Tarján E; Spät A; Balla T; Székely A
    Acta Endocrinol (Copenh); 1980 Jul; 94(3):381-8. PubMed ID: 6158822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone biosynthesis. Interrelationship of regulatory factors.
    Williams GH; Dluhy RG
    Am J Med; 1972 Nov; 53(5):595-605. PubMed ID: 4342886
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of the renin-angiotensin-aldosterone system in patients with hypertension and in normal subjects.
    Streeten DH; Schletter FE; Clift GV; Stevenson CT; Dalakos TG
    Am J Med; 1969 Jun; 46(6):844-61. PubMed ID: 4307877
    [No Abstract]   [Full Text] [Related]  

  • 27. Elevated 'free' 18-hydroxy-corticosterone excretion as a possible indicator for early diagnosis of primary aldosteronism.
    Abdelhamid S; Vecsei P; Haack D; Gless KH; Walb D; Fiegel P; Lichtwald K
    J Steroid Biochem; 1981 Sep; 14(9):913-20. PubMed ID: 7029142
    [No Abstract]   [Full Text] [Related]  

  • 28. On the role of aldosterone to hypertension, especially an extent of its participation.
    Oda T
    Jpn Circ J; 1971 May; 35(5):513-8. PubMed ID: 4326119
    [No Abstract]   [Full Text] [Related]  

  • 29. Pseudohypoaldosteronism: persistence of hyperaldosteronism and evidence for renal tubular and intestinal responsiveness to endogenous aldosterone.
    Postel-Vinay MC; Alberti GM; Ricour C; Limal JM; Rappaport R; Royer P
    J Clin Endocrinol Metab; 1974 Dec; 39(6):1038-44. PubMed ID: 4372243
    [No Abstract]   [Full Text] [Related]  

  • 30. Vasodilating antihypertensive drug-induced aldosterone release--a study of endogenous angiotensin-mediated aldosterone release in the rat.
    Campbell WB; Pettinger WA; Keeton K; Brooks SN
    J Pharmacol Exp Ther; 1975 Apr; 193(1):166-75. PubMed ID: 1167223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agents which block the action of the renin-angiotensin system.
    Davis JO; Freeman RH; Johnson JA; Spielman WS
    Circ Res; 1974 Mar; 34(3):279-85. PubMed ID: 4362035
    [No Abstract]   [Full Text] [Related]  

  • 32. Renin and hypertension.
    Verniory A; Staroukine M; Delwiche F
    Brux Med; 1973 Nov; Spec No(0):63-86. PubMed ID: 4371909
    [No Abstract]   [Full Text] [Related]  

  • 33. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of aldosterone secretion by the renin-angiotensin system and by corticotropin.
    Gross F
    Adv Intern Med; 1968; 14():281-339. PubMed ID: 4303034
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.
    Newton MA; Laragh JH
    J Clin Endocrinol Metab; 1968 Jul; 28(7):1006-13. PubMed ID: 4298942
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of sodium restriction on urinary excretion of 19-noraldosterone and 18,19-dihydroxycorticosterone, newly identified mineralocorticoids in man.
    Takeda Y; Miyamori I; Takeda R; Lewicka S; Vecsei P
    J Clin Endocrinol Metab; 1992 May; 74(5):1195-7. PubMed ID: 1569167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Renin-angiotensin-aldosterone system: the present status and problems].
    Khristov V
    Vutr Boles; 1979; 18(6):8-15. PubMed ID: 392945
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experimental bases of the pathophysiology of the renin-angiotensin system].
    Gross F
    Verh Dtsch Ges Inn Med; 1968; 74():27-41. PubMed ID: 4306314
    [No Abstract]   [Full Text] [Related]  

  • 39. Application of radioimmunoassay to the renin-angiotensin system and to aldosterone.
    Ulick S
    Metabolism; 1973 Aug; 22(8):1027-32. PubMed ID: 4354161
    [No Abstract]   [Full Text] [Related]  

  • 40. Renin-angiotensin-aldosterone system in hypertension. The clinical usefulness of measuring components of thisystem.
    Ayers CR
    Va Med Mon (1918); 1969 Jun; 96(6):312-4. PubMed ID: 4308355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.